3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
11
Prostatic Neoplasms
7
Fallopian Tube Neoplasms
5
Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms, Castration-Resistant
2
Neoplasm Metastasis
2
Glioblastoma
2
Carcinoma, Ovarian Epithelial
2
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Prostate Adenocarcinoma
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
1
Metastatic Castration-sensitive Prostate Cancer
1
Lung Neoplasms
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Glioma
1
Endometrial Neoplasms
1
Disease Progression
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Cyclophosphamide
9
X-Rays
8
Specimen Handling
8
Phantoms, Imaging
7
fludarabine
6
Magnetic Resonance Spectroscopy
6
cabozantinib
5
Biopsy
5
Nuclear Medicine Department, Hospital
4
Methotrexate
4
Gemcitabine
4
Doxorubicin
4
irinotecan sucrosofate
3
fludarabine phosphate
3
Vincristine
3
Temozolomide
3
Ifosfamide
3
Cisplatin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
pembrolizumab
2
palbociclib
2
olaparib
2
mifamurtide
2
larotrectinib
2
ivosidenib
2
ensartinib
2
Surgical Procedures, Operative
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
niraparib
×
90 days
×
Clear all
No trials found.